Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
CONCLUSIONS: This is the most extensive systematic assessment of effects of omega-3 fats on cardiovascular health to date. Moderate- and low-certainty evidence suggests that increasing LCn3 slightly reduces risk of coronary heart disease mortality and events, and reduces serum triglycerides (evidence mainly from supplement trials). Increasing ALA slightly reduces risk of cardiovascular events and arrhythmia.
PMID: 32114706 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L Tags: Cochrane Database Syst Rev Source Type: research
More News: Arrhythmia | Cardiology | Cardiovascular | Clinical Trials | Coronary Heart Disease | Databases & Libraries | Diets | Fish | General Medicine | Heart | Heart Disease | International Medicine & Public Health | Lovaza | Nutrition | Omega 3 | Stroke | WHO